1 in 8 men will be diagnosed with prostate cancer during their lifetime. Prostate cancer often shows no symptoms in its early stages, making regular screenings and physician check-ups key for men, especially those over 50. Early detection can lead to effective management and treatment, which is why awareness and education are so crucial. Let's use this month to spread the word about the importance of regular health screenings and proactive healthcare. Encourage the men in your life to stay informed and get checked regularly. Together, we can fight prostate cancer 🎗 #ProstateCancerAwareness #EarlyDetectionSavesLives #GenomateHealth
Genomate Health
Health and Human Services
Cambridge, MA 1,561 followers
The right drug. The first time. Every time.™ AI-powered clinical decision support for precision oncology.
About us
Genomate Health Inc. is a medical technology company based in Cambridge, MA. It builds powerful computational models that harness the knowledge of published scientific evidence and clinical experience augmented with computational reasoning. These models enable AI-guided treatment based on each patient’s unique disease. Our flagship product, Genomate®, is the first computational AI solution that has been clinically proven to improve personalized N-of-1 treatment decisions in precision oncology. It automates data compilation, evaluation, and synthesis in a knowledge model allowing standardized, personalized treatment decisions based on the totality of available molecular information. We're currently partnering with cancer centers, molecular diagnostic companies, insurance companies, health funds, and pharma companies to advance access to effective targeted therapies for cancer patients worldwide. Join us!
- Website
-
http://genomate.health
External link for Genomate Health
- Industry
- Health and Human Services
- Company size
- 11-50 employees
- Headquarters
- Cambridge, MA
- Type
- Privately Held
- Founded
- 2022
Locations
-
Primary
Cambridge, MA, US
Employees at Genomate Health
-
Jared Schrieber
Father of 3 amazing humans, a unicorn, a robot and a book. CEO & Co-founder of STEAM Academy. Previously CEO and Co-founder of InfoScout (now…
-
Scott Friedman
Partner , Lippes Mathias LLP, Co-Founder & Managing Director, Varia Ventures; Author; Board Member
-
Istvan Petak, MD, PhD
Physician-Scientist, Professor of Molecular Pharmacology, Founder of medical technology companies, Precision oncology enthusiast, Supporter of…
-
Robert Doczi, PhD
Head of Research at Genomate Health
Updates
-
Genomate Health reposted this
Physician-Scientist, Professor of Molecular Pharmacology, Founder of medical technology companies, Precision oncology enthusiast, Supporter of CancerX, Father of three wonderful humans
Hello Amazing Budapest, Hello Amazing AI Summit Budapest! AI is transforming all aspects of our lives. It was my privilege to give a keynote presentation on how AI is advancing our fight against cancer. I also had the opportunity to deliver some of the primary critical messages of the CancerX Moonshot Summit in Washington from the previous week. Our mission at Genomate Health is to find the right targeted therapy for cancer patients based on their tumor's molecular profile wherever they live. AI must also decrease inequality in healthcare. All cancer patients should have access to the best available therapies. #precisiononcology #artificialintelligence
-
In Budapest for #AISummit2024? Join our founder, Istvan Petak, MD, PhD, as he dives deep into what AI solutions are available in healthcare today and how cancer research benefits from them on the Media Future Stage. Don't miss out on the chance to ask all your questions: https://lnkd.in/dAtdedjZ AI Summit Budapest
📣ITT VANNAK A NAPIJEGYEK az AI Summit Budapestre!!!‼️ Már mindkét napra elérhetőek napijegyek is korlátozott számban a régió legnagyobb mesterséges intelligencia konferenciájára! 2 nap az AI jegyében, 2 helyszín, több mint 150 előadóval!💡 🎫Ne maradj le róla: https://aisummit.hu/#price
-
Gynecologic cancers affect thousands of women, but the symptoms can often be difficult to recognize. These cancers, which include ovarian, cervical, endometrial, uterine sarcoma, vulvar, and vaginal cancer, all begin in a woman’s reproductive tract. Each type is unique, and awareness is key to catching them early, when treatments are most effective. If you or someone you love is experiencing unusual symptoms, don’t hesitate to consult your doctor. Early detection can make all the difference. This month, let’s come together to raise awareness, support each other, and encourage conversations about women’s health 🎗️ #GynecologicCancerAwareness #WomensHealth #EarlyDetectionSavesLives #GenomateHealth
-
Genomate Health reposted this
Hello Birmingham, thank you Plug and Play UK for an amazing workshop and networking event. 🇬🇧 Pleased to be part of this MedTech innovation community on our journey to improve treatment outcomes for patients and to build corporate partnerships by providing solutions in precision oncology.
-
Genomate Health reposted this
Today, representatives from the 150+ CancerX member organizations gathered for our annual member meeting. They convened with federal representatives to share cancer priorities and align the CancerX mission, goals, and vision for #digitalinnovation for the year ahead. The resultant CancerX priorities and activities coming from this meeting target outsized impact through knowledge exchange and collaboration by: ▪️Establishing areas of unmet need in #cancer research and care that digital health solutions can address ▪️Generating concepts to inform projects and accelerator activities that leverage digital innovations ▪️Facilitating opportunities for collaboration within the CancerX community and federal representatives And this is just the beginning! Stay tuned for what’s next from CancerX by signing up for our newsletter: https://lnkd.in/eesphEc2 #CancerXSummit2024 Digital Medicine Society (DiMe) Moffitt Cancer Center Assistant Secretary for Technology Policy and Office of the Assistant Secretary for Health (OASH)
-
+2
-
It's #ChildhoodCancerAwarenessMonth! This month, we stand with the brave children and families facing the challenges of childhood cancer. Every year, thousands of children are diagnosed with cancer, and their journeys are filled with courage, resilience, and hope. At Genomate Health, we're committed to advancing precision oncology to bring more personalized, effective treatments to young patients. Our study, published in the World Journal of Pediatrics, showcases the real-world impact of our technology. Genomate identified actionable targeted treatment options for 72% of pediatric cancer patients, with the molecular tumor board approving these therapies in 78% of cases—rising to 88% by 2020, thanks to continuous updates in our evidence database. 🔗 Read the full study: https://lnkd.in/d3s2aNm9 Let’s work together to raise awareness, support research, and drive innovation to improve outcomes for all children battling cancer. 💛 #GenomateHealth #PrecisionOncology #PediatricCancer
-
We couldn't be happier to be in such great company! 🎉
We're thrilled to introduce you to Genomate Health—another groundbreaking start-up from Plug and Play UK's Health Program Batch 2! 🩺🚀 Genomate is revolutionising cancer treatment by using advanced computational reasoning to personalise therapy based on each patient's unique genetic profile. This approach significantly enhances treatment effectiveness and improves patient outcomes. With cancer affecting 1 in 2 people and 93% of patients missing out on effective targeted therapies, Genomate’s technology is closing this gap. Genomate has developed the world’s first clinically validated computational reasoning intelligence platform for precision oncology. This platform can predict responses to thousands of targeted therapies in milliseconds, based on millions of potential combinations of genetic biomarkers. Welcome to the cohort, Genomate Health! We’re excited to watch your progress in the coming weeks. 🎉 ___ Plug and Play UK’s Health Accelerator is being delivered as part of the West Midlands Health Tech Innovation Accelerator - WMHTIA, funded by the Department for Science, Innovation and Technology, in partnership with Innovate UK and the West Midlands Combined Authority. Ademen Ltd Cytecom EarSwitch Genomate Health Holly Health Intelligent Assist Medherant Limited MESOX Praxium AI Pyrexia #PNPUK #healthtech #nhs #futurehealth
-
Genomate Health reposted this
Have you checked out the latest resources from CancerX? 🚀 Yesterday, we were thrilled to launch the Digital Navigation ROI Calculator and the Digitally Enabled Patient Navigation Blueprint to quantify and optimize the return on investment (ROI) for health systems that embrace digitally enabled patient navigation programming. 🎥 We were joined by industry leaders - including Anabella Aspiras from The White House - who discussed how these resources prove the value of investing in #digital navigation programming to reduce patient #financial toxicity and, ultimately, impact survival outcomes. In case you missed the event or would like to refer back to our discussion, you can access the recording of our public launch event here: https://lnkd.in/dv529EJN CancerX is committed to reducing #cancer-related mortality rates and enhancing the quality of life for patients and their families through digital innovation. By empowering and supporting more patient navigators within health and provider systems, these resources directly contribute to improving patient outcomes. Access the resources: https://lnkd.in/ekc9Z37b American Cancer Society Biofourmis Blue Note Therapeutics Cancer Support Community City of Hope Current Health Family Reach Folia Health: The Home-Reported Outcomes Company Genomate Health Kaiser Permanente The Leukemia & Lymphoma Society Lightship Memorial Sloan Kettering Cancer Center Our National Conversation (ONC) Oracle Pluto Health Science 37 Sidekick Health Takeda Digital Ventures Tempus AI Touch, The Black Breast Cancer Alliance U.S. Department of Veterans Affairs
-
Last week, we were proud to be represented by our distributors, Digosys, at the AI4VN 2024 conference in Hanoi. This event brought together leading innovators in AI, and we’re thrilled to be part of the conversation on how AI is transforming healthcare in Vietnam and beyond. A huge thank you to Digosys for showcasing our precision oncology solutions and demonstrating how Genomate is revolutionizing cancer care by tailoring treatments to each patient’s unique genetic profile. Together, we’re making personalized, effective treatments accessible to more patients around the world. #AI4VN #GenomateHealth #Digosys #PrecisionOncology